Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.74 |
| ▸ | TSHR | P16473 | 2/20 | 0.74 |
| ▸ | KARS1 | Q15046 | 1/20 | 0.74 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.74 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.74 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.74 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.74 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.74 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.74 |
| ▸ | TP53 | P04637 | 1/20 | 0.72 |
| ▸ | MAPT | P10636 | 1/20 | 0.72 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 10/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19174219 | 1.00 | MEN1 (0.74) | MEN1CYP3A4KMT2ATSHRKARS1 | |
| SCHEMBL17470671 | 1.00 | MEN1 (0.74) | MEN1CYP3A4KMT2ATSHRKARS1 | |
| SCHEMBL239240 | 1.00 | MEN1 (0.74) | MEN1CYP3A4KMT2ATSHRKARS1 | |
| SCHEMBL289598 | 0.95 | MEN1 (0.77) | MEN1CYP3A4KMT2ATSHRKARS1 | |
| SCHEMBL14496633 | 0.90 | TDP1 (0.76) | MEN1CYP3A4KMT2ATSHRKARS1 | |
| SCHEMBL18431217 | 0.90 | TDP1 (0.76) | MEN1CYP3A4KMT2ATSHRKARS1 | |
| SCHEMBL18431216 | 0.89 | MEN1 (0.74) | MEN1CYP3A4KMT2ATSHRKARS1 | |
| SCHEMBL16204336 | 0.89 | MEN1 (0.74) | MEN1CYP3A4KMT2ATSHRKARS1 | |
| SCHEMBL9112389 | 0.88 | TDP1 (0.68) | MEN1CYP3A4KMT2ATSHRKARS1 | |
| SCHEMBL14496652 | 0.88 | TDP1 (0.63) | MEN1CYP3A4KMT2ATSHRKARS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10463 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746863-A1 | ENDOXIFEN COMPOSITIONS AND METHODS OF USE THEREOF AND SYNTHESIS THEREOF | Atossa Therapeutics, Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| WO-2026101937-A1 | COMPOSITIONS COMPRISING (Z)-ENDOXIFEN AND A CDK4/6 INHIBITOR AND METHODS OF USE THEREOF | ATOSSA THERAPEUTICS, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| WO-2026044024-A1 | COMPOSITIONS COMPRISING COMBINATIONS OF PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF AMYLIN ANALOG, AND USES THEREOF | I2O THERAPEUTICS, INC. (US) | 2026-02-26 | — | — | WO | claimed |
| US-20250387385-A1 | TREATMENT FOR GLOMERULAR DISEASES | ZYDUS LIFESCIENCES LIMITED (IN) | 2025-12-25 | — | — | US | claimed |
| US-20250375461-A1 | IDENTIFICATION OF A NEW POTENT INHIBITOR OF MYCOBACTERIAL GROWTH | UNIV BROWN (US) | 2025-12-11 | — | — | US | claimed |
| US-20250353840-A1 | SOLID FORMS OF (Z)-4-(5-((3-BENZYL-4-OXO-2-THIOXOTHIAZOLIDIN-5-YLIDENE) METHYL)FURAN-2-YL)BENZOIC ACID | ATEGRIN INC (US) | 2025-11-20 | — | — | US | claimed |
| WO-2025151443-A1 | ENDOXIFEN FOR TREATMENT OF RARE CANCERS | ATOSSA THERAPEUTICS, INC. (US) | 2025-07-17 | — | — | WO | claimed |
| WO-2025137145-A1 | ORAL FORMULATIONS OF (Z)-ENDOXIFEN AND METHODS OF USE THEREOF | ATOSSA THERAPEUTICS, INC. (US) | 2025-06-26 | — | — | WO | claimed |
| EP-4565233-A1 | TREATMENT FOR APLASTIC ANEMIA (AA) | Zydus Lifesciences Limited (IN) | 2025-06-11 | — | — | EP | claimed |
| EP-4539934-A1 | TREATMENT FOR GLOMERULAR DISEASES | Zydus Lifesciences Limited (IN) | 2025-04-23 | — | — | EP | claimed |
| WO-2022250499-A1 | ORAL AQUEOUS SUSPENSION FORMULATIONS COMPRISING CARBAMATE COMPOUND | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2022-12-01 | — | — | WO | claimed |
| US-20220370413-A1 | FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY | Mind Medicine, Inc. (US) | 2022-11-24 | — | — | US | claimed |
| CN-115335363-A | Benzimidazole compounds for the treatment of metabolic disorders | 艾奇实验室制药有限公司 | 2022-11-11 | — | — | CN | claimed |
| US-11459341-B1 | Organic anion lithium ionic cocrystal compounds and compositions | UNIVERSITY OF SOUTH FLORIDA (US) | 2022-10-04 | — | — | US | claimed |
| WO-2022195532-A1 | TREATMENT FOR SICKLE CELL ANAEMIA | ZYDUS LIFESCIENCES LTD. (IN) | 2022-09-22 | — | — | WO | claimed |
| WO-2022192097-A1 | FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY | Mind Medicine, Inc. (US) | 2022-09-15 | — | — | WO | claimed |
| US-20220280482-A1 | FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY | Mind Medicine, Inc. (US) | 2022-09-08 | — | — | US | claimed |
| WO-2022129210-A2 | INHIBITION OF VIRUS PROTEASE | HELMHOLTZ ZENTRUM MUENCHEN - DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) | 2022-06-23 | — | — | WO | claimed |
| CN-109310686-B | Soluble C5aR antagonists | 凯莫森特里克斯股份有限公司 | 2022-06-21 | — | — | CN | claimed |
| WO-2022047234-A1 | DRUG COMBINATION KITS AND METHODS OF DRUG DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-03-03 | — | — | WO | claimed |